Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.
Das größere Signal: KI wandert von Demos in Budgets, Regeln, Sicherheitsabläufe und Kapitalallokation.
Quellen: BusinessWire; BioSpace; Precision Medicine Online; CocoLoop, CocoLoop.